Please enable JavaScript to continue using this application.

Compare $FRMM vs $RNTX | Chartloom

Compare

$FRMM vs $RNTX

Forum Markets, Inc · Rein Therapeutics Inc

FRMM

Forum Markets, Inc

RNTX

Rein Therapeutics Inc

Compare $FRMM vs $RNTX

Comparing Forum Markets, Inc and Rein Therapeutics Inc

FRMMForum Markets, Inc

RNTXRein Therapeutics Inc

FRMMForum Markets, Inc

Market cap

$59M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.70x

Rev growth (TTM)

—

YTD performance

-12.3%

52W performance

-80.7%

FCF yield

-124.7%

RNTXRein Therapeutics Inc

Market cap

$68M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.5%

52W performance

-42.9%

FCF yield

-27.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FRMM

RNTX

Detailed metrics comparison

FRMM

Forum Markets, Inc

RNTX

Rein Therapeutics Inc

Market Cap

FRMM$59M

RNTX$68M

Enterprise Value

FRMM$59M

RNTX$59M

Price

FRMM$4.48

RNTX$0.79

P/E Ratio

FRMMN/A

RNTXN/A

P/S Ratio

FRMM5.49x

RNTX0.00x

EV/Sales

FRMM5.49x

RNTX0.00x

EV/EBITDA

FRMM0.00x

RNTX0.00x

P/B Ratio

FRMM0.27x

RNTX1.25x

P/FCF Ratio

FRMMN/A

RNTXN/A

EV/FCF

FRMM-0.80x

RNTX-3.15x

PEG Ratio

FRMMN/A

RNTXN/A

Forward P/E (NTM)

FRMMN/A

RNTXN/A

Forward P/S (NTM)

FRMM1.70x

RNTXN/A

Revenue (TTM)

FRMM$11M

RNTX$0

Revenue Growth (YoY)

FRMMN/A

RNTXN/A

Forward Rev Growth

FRMM132.9%

RNTX113.7%

Gross Margin (TTM)

FRMM3.7%

RNTX0.0%

Operating Margin (TTM)

FRMM0.0%

RNTX0.0%

EBITDA Margin (TTM)

FRMM-122.2%

RNTX0.0%

Net Margin (TTM)

FRMM-4971.8%

RNTX0.0%

FCF Margin (TTM)

FRMM-684.9%

RNTXN/A

Net Income (TTM)

FRMM$-536M

RNTX$-50M

FCF (TTM)

FRMM$-74M

RNTX$-19M

EPS (TTM)

FRMM-$31.38

RNTX-$0.74

ROE (TTM)

FRMM-25831.0%

RNTX-15323.0%

ROA (TTM)

FRMM-13469.0%

RNTX-11700.0%

ROIC (TTM)

FRMM-14374.0%

RNTX-14763.0%

Cash

FRMM$0

RNTX$9M

Debt

FRMM$0

RNTX$0

Net Cash/Debt

FRMM$0

RNTX$9M

Current Ratio (TTM)

FRMM0.33x

RNTX4.27x

Quick Ratio (TTM)

FRMM0.22x

RNTX4.26x

Debt/Equity (TTM)

FRMM0.24x

RNTX0.00x

Debt/Assets (TTM)

FRMM0.0%

RNTX0.0%

Interest Coverage (TTM)

FRMMN/A

RNTXN/A

Net Debt/EBITDA (TTM)

FRMM0.00x

RNTX0.00x

Beta

FRMM1.66

RNTX1.40

52W Performance

FRMM-80.7%

RNTX-42.9%

YTD Performance

FRMM-12.3%

RNTX-36.5%

% from 52W High

FRMM-81.7%

RNTX-63.6%

% from 52W Low

FRMM154.5%

RNTX14.4%

Asset Turnover (TTM)

FRMM0.00x

RNTX0.00x

FCF Yield (TTM)

FRMM-124.7%

RNTX-27.7%

Earnings Yield (TTM)

FRMM-904.9%

RNTX-73.3%

Dividend Yield (TTM)

FRMMN/A

RNTXN/A

Rule of 40

FRMM-684.9

RNTX0.0

EV/GP/RG

FRMM0.67

RNTXN/A

Ticker research

View FRMM research View RNTX research

Metric	FRMM Forum Markets, Inc	RNTX Rein Therapeutics Inc
Market & Valuation
Market Cap	$59M	$68M
Enterprise Value	$59M	$59M
Price	$4.48	$0.79
P/E Ratio	N/A	N/A
P/S Ratio	5.49x	0.00x
EV/Sales	5.49x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.27x	1.25x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.80x	-3.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.70x	N/A
Revenue & Growth
Revenue (TTM)	$11M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	132.9%	113.7%
Profitability
Gross Margin (TTM)	3.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-122.2%	0.0%
Net Margin (TTM)	-4971.8%	0.0%
FCF Margin (TTM)	-684.9%	N/A
Net Income (TTM)	$-536M	$-50M
FCF (TTM)	$-74M	$-19M
EPS (TTM)	-$31.38	-$0.74
ROE (TTM)	-25831.0%	-15323.0%
ROA (TTM)	-13469.0%	-11700.0%
ROIC (TTM)	-14374.0%	-14763.0%
Financial Health
Cash	$0	$9M
Debt	$0	$0
Net Cash/Debt	$0	$9M
Current Ratio (TTM)	0.33x	4.27x
Quick Ratio (TTM)	0.22x	4.26x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.40
52W Performance	-80.7%	-42.9%
YTD Performance	-12.3%	-36.5%
% from 52W High	-81.7%	-63.6%
% from 52W Low	154.5%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-124.7%	-27.7%
Earnings Yield (TTM)	-904.9%	-73.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-684.9	0.0
EV/GP/RG	0.67	N/A
Ticker research	View FRMM research	View RNTX research

Valuation

P/S Ratio

RNTX

0.00x

FRMM

5.49x

EV/FCF

RNTX

-3.15x

FRMM

-0.80x

Growth & revenue

Forward Revenue Growth

FRMM

132.9%

RNTX

113.7%

Profitability & performance

Gross Margin

FRMM

3.7%

RNTX

0.0%

ROE

RNTX

-15323.0%

FRMM

-25831.0%

FCF Yield %

RNTX

-27.7%

FRMM

-124.7%

52-Week Performance

RNTX

-42.9%

FRMM

-80.7%

Detailed metrics comparison

FRMM

Forum Markets, Inc

RNTX

Rein Therapeutics Inc

Market Cap

FRMM$59M

RNTX$68M

Enterprise Value

FRMM$59M

RNTX$59M

Price

FRMM$4.48

RNTX$0.79

P/E Ratio

FRMMN/A

RNTXN/A

P/S Ratio

FRMM5.49x

RNTX0.00x

EV/Sales

FRMM5.49x

RNTX0.00x

EV/EBITDA

FRMM0.00x

RNTX0.00x

P/B Ratio

FRMM0.27x

RNTX1.25x

P/FCF Ratio

FRMMN/A

RNTXN/A

EV/FCF

FRMM-0.80x

RNTX-3.15x

PEG Ratio

FRMMN/A

RNTXN/A

Forward P/E (NTM)

FRMMN/A

RNTXN/A

Forward P/S (NTM)

FRMM1.70x

RNTXN/A

Revenue (TTM)

FRMM$11M

RNTX$0

Revenue Growth (YoY)

FRMMN/A

RNTXN/A

Forward Rev Growth

FRMM132.9%

RNTX113.7%

Gross Margin (TTM)

FRMM3.7%

RNTX0.0%

Operating Margin (TTM)

FRMM0.0%

RNTX0.0%

EBITDA Margin (TTM)

FRMM-122.2%

RNTX0.0%

Net Margin (TTM)

FRMM-4971.8%

RNTX0.0%

FCF Margin (TTM)

FRMM-684.9%

RNTXN/A

Net Income (TTM)

FRMM$-536M

RNTX$-50M

FCF (TTM)

FRMM$-74M

RNTX$-19M

EPS (TTM)

FRMM-$31.38

RNTX-$0.74

ROE (TTM)

FRMM-25831.0%

RNTX-15323.0%

ROA (TTM)

FRMM-13469.0%

RNTX-11700.0%

ROIC (TTM)

FRMM-14374.0%

RNTX-14763.0%

Cash

FRMM$0

RNTX$9M

Debt

FRMM$0

RNTX$0

Net Cash/Debt

FRMM$0

RNTX$9M

Current Ratio (TTM)

FRMM0.33x

RNTX4.27x

Quick Ratio (TTM)

FRMM0.22x

RNTX4.26x

Debt/Equity (TTM)

FRMM0.24x

RNTX0.00x

Debt/Assets (TTM)

FRMM0.0%

RNTX0.0%

Interest Coverage (TTM)

FRMMN/A

RNTXN/A

Net Debt/EBITDA (TTM)

FRMM0.00x

RNTX0.00x

Beta

FRMM1.66

RNTX1.40

52W Performance

FRMM-80.7%

RNTX-42.9%

YTD Performance

FRMM-12.3%

RNTX-36.5%

% from 52W High

FRMM-81.7%

RNTX-63.6%

% from 52W Low

FRMM154.5%

RNTX14.4%

Asset Turnover (TTM)

FRMM0.00x

RNTX0.00x

FCF Yield (TTM)

FRMM-124.7%

RNTX-27.7%

Earnings Yield (TTM)

FRMM-904.9%

RNTX-73.3%

Dividend Yield (TTM)

FRMMN/A

RNTXN/A

Rule of 40

FRMM-684.9

RNTX0.0

EV/GP/RG

FRMM0.67

RNTXN/A

Ticker research

View FRMM research View RNTX research

Metric	FRMM Forum Markets, Inc	RNTX Rein Therapeutics Inc
Market & Valuation
Market Cap	$59M	$68M
Enterprise Value	$59M	$59M
Price	$4.48	$0.79
P/E Ratio	N/A	N/A
P/S Ratio	5.49x	0.00x
EV/Sales	5.49x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.27x	1.25x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.80x	-3.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.70x	N/A
Revenue & Growth
Revenue (TTM)	$11M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	132.9%	113.7%
Profitability
Gross Margin (TTM)	3.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-122.2%	0.0%
Net Margin (TTM)	-4971.8%	0.0%
FCF Margin (TTM)	-684.9%	N/A
Net Income (TTM)	$-536M	$-50M
FCF (TTM)	$-74M	$-19M
EPS (TTM)	-$31.38	-$0.74
ROE (TTM)	-25831.0%	-15323.0%
ROA (TTM)	-13469.0%	-11700.0%
ROIC (TTM)	-14374.0%	-14763.0%
Financial Health
Cash	$0	$9M
Debt	$0	$0
Net Cash/Debt	$0	$9M
Current Ratio (TTM)	0.33x	4.27x
Quick Ratio (TTM)	0.22x	4.26x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.40
52W Performance	-80.7%	-42.9%
YTD Performance	-12.3%	-36.5%
% from 52W High	-81.7%	-63.6%
% from 52W Low	154.5%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-124.7%	-27.7%
Earnings Yield (TTM)	-904.9%	-73.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-684.9	0.0
EV/GP/RG	0.67	N/A
Ticker research	View FRMM research	View RNTX research